In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Safety of 3-Bromo-1,5-naphthyridine, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 17965-71-8, name is 3-Bromo-1,5-naphthyridine. In an article£¬Which mentioned a new discovery about 17965-71-8
Crystallography has guided the hybridization of two series of Trypanosoma brucei N-myristoyltransferase (NMT) inhibitors, leading to a novel highly selective series. The effect of combining the selectivity enhancing elements from two pharmacophores is shown to be additive and has led to compounds that have greater than 1000-fold selectivity for TbNMT vs HsNMT. Further optimization of the hybrid series has identified compounds with significant trypanocidal activity capable of crossing the blood-brain barrier. By using CF-1 mdr1a deficient mice, we were able to demonstrate full cures in vivo in a mouse model of stage 2 African sleeping sickness. This and previous work provides very strong validation for NMT as a drug target for human African trypanosomiasis in both the peripheral and central nervous system stages of disease.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 17965-71-8, help many people in the next few years.Safety of 3-Bromo-1,5-naphthyridine
Reference£º
1,594-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N588 – PubChem